- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Congress Must Act for Cannabis Patients! Pass Medical Cannabis Legislation NOW! Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2021 State of the States Medical Cannabis Access for Pain Treatment Cannabis and Cannabis Resin- Critical Review Preparation Document Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- Join Join
Medical Marijuana Access in The U.S.
Americans For Safe Access is proud to announce the 2017 edition of our Medical Marijuana Access in the United States report. Beginning in 2014 ASA recognized the need to evaluate and compare the myriad of medical cannabis laws across the country. To this end we worked with our members and patients nationwide to develop a grading matrix that would indicate how well a states laws met the needs of patients.
With medical cannabis programs now encompassing 44 states, the District of Columbia and the territories of Puerto Rico and Guam, 300 million Americans (85% of the population) now live in states with medical cannabis laws.
This report is intended to help law makers and regulators learn from the successes and challenges faced by their peers in other states and get an objective evaluation of their own program.
The report uses a point system to grade each medical marijuana law on:
- Patients' rights and protection from discrimination
- Access to medicine
- Ease of navigation
- Product safety protocols
We're happy to report that despite the grades of a few states declining in 2016, overall our nation's grades are improving and we were excited to see some new states enter the report starting off on a very good foot.
Letter-grades for all 44 states and Washington, D.C.: Alabama (F-), Alaska (D-), Arizona (B-), Arkansas (B-), California (B+), Colorado (B-), Connecticut (B-), Delaware (C+), Florida (B-), Georgia (F-), Hawai'i (B), Illinois (B+), Iowa (F-), Kentucky (F-), Louisiana (F-), Maine (B), Maryland (C), Massachusetts (B-), Michigan (B+), Minnesota (C-), Mississippi (F-), Missouri (F-), Montana (B), Nevada (B), New Hampshire (B-), New Jersey (C), New Mexico (B), New York (C), North Carolina (F-), North Dakota (C), Ohio (B), Oklahoma (F-), Oregon (B), Pennsylvania (B-), Rhode Island (C+), South Carolina (F-), Tennessee (F-), Texas (F-), Utah (F-), Vermont (C-), Virginia (F-), Washington (C-), Wisconsin (F-), Wyoming (F-), and the District of Columbia (B-).